Active Stocks
Fri Apr 19 2024 10:25:48
  1. Tata Steel share price
  2. 160.50 0.31%
  1. Tata Motors share price
  2. 952.25 -1.97%
  1. Infosys share price
  2. 1,396.65 -1.68%
  1. ITC share price
  2. 424.55 1.34%
  1. NTPC share price
  2. 348.35 -0.87%
Business News/ Companies / Wockhardt launches new insulin Glaritus in India
BackBack

Wockhardt launches new insulin Glaritus in India

Wockhardt launches new insulin Glaritus in India

Premium

Mumbai: Drug major Wockhardt on Tuesday launched an insulin Glaritus, used in the treatment of diabetes, in the country.

“This new insulin Glaritus has been successfully clinically tested on 300 diabetic patients for safety and efficacy parameters and is approved by the Drug Controller General of India," Wockhardt said in a statement.

As per ORG IMS, the current analogous market in India is worth Rs120 crore and is growing at a rate of 37% annually, the company said.

Insulin analogous are advanced insulin therapies for diabetic comprising genetically engineered human insulin molecules.

Unlock a world of Benefits! From insightful newsletters to real-time stock tracking, breaking news and a personalized newsfeed – it's all here, just a click away! Login Now!

Catch all the Corporate news and Updates on Live Mint. Download The Mint News App to get Daily Market Updates & Live Business News.
More Less
Published: 10 Feb 2009, 08:49 PM IST
Next Story footLogo
Recommended For You
Switch to the Mint app for fast and personalized news - Get App